Education
About Us
Working with TipRanks
Follow Us
Mgp Ingredients (MGPI)
NASDAQ:MGPI
Top Page
MGP Ingredients
(NASDAQ:MGPI)
Select Model
Select Model
Rating:46Neutral
Price Target:
$17.00
▼(-32.30% Downside)
Action:ReiteratedDate:02/26/26
The score is weighed down primarily by the FY2025 earnings collapse and downtrending revenue, plus weak price/indicator momentum. Guidance points to another pressured year with notable cash outflows and higher leverage risk, while cash generation and reduced debt provide some offset and the dividend offers modest support.
Positive Factors
Operating Cash Generation
Consistent high operating cash flow and improved free cash flow provide durable liquidity that supports capital spending, dividends, and debt service even when accounting earnings are weak. This cash resilience underpins refinancing and strategic flexibility over the next 2–6 months.
Branded Spirits Momentum (Penelope/Premium Plus)
Rapid, sustained growth in Penelope and Premium Plus indicates strong consumer demand, expanding distribution, and rising brand equity. Durable brand momentum supports higher-margin branded revenue, enhances pricing power and channel leverage, and reduces reliance on commoditized bulk sales.
Ingredient Solutions Operational Recovery
Operational reliability improvements and rising extrusion protein demand point to a recovery in higher-margin specialty ingredients. Restored production and expected mid‑to‑high‑teens gross margins diversify revenue and stabilize earnings beyond volatile distilling markets.
Negative Factors
Revenue Downtrend and FY2025 Loss
A multiyear revenue decline culminating in a large net loss weakens return generation and raises the bar for recovery. Persistent top-line contraction reduces operating leverage, pressures margins, and can erode equity if losses continue, constraining long‑term reinvestment.
Distilling Solutions Structural Weakness
A severe, multi-quarter collapse in Distilling Solutions reflects industry oversupply and weak brown‑goods demand. Given its material revenue share, continued weakness will depress consolidated gross profit and increase earnings volatility until structural demand or mix shifts occur.
Near‑Term Cash Outflow and Elevated Leverage
A large, contractual earn‑out and upcoming convertible refinancing will materially raise net leverage and cut operating cash flow in 2026. Higher leverage reduces financial flexibility, increases refinancing risk and interest burdens, and constrains the company's ability to invest during a recovery phase.
MGP Ingredients (MGPI) vs. SPDR S&P 500 ETF (SPY)
Market Cap
$364.03M
Dividend Yield2%
Average Volume (3M)332.73K
Price to Earnings (P/E)―
Beta (1Y)0.87
Revenue Growth-21.53%
EPS Growth-113.89%
CountryUS
Employees660
SectorConsumer Defensive
Sector Strength42
IndustryBeverages - Wineries & Distilleries
Share Statistics
EPS (TTM)0.63
Shares Outstanding21,363,226
10 Day Avg. Volume313,520
30 Day Avg. Volume332,728
Financial Highlights & Ratios
PEG Ratio0.01
Price to Book (P/B)0.72
Price to Sales (P/S)0.97
P/FCF Ratio6.83
Enterprise Value/Market Cap1.68
Enterprise Value/Revenue1.14
Enterprise Value/Gross Profit3.07
Enterprise Value/Ebitda-8.14
Forecast
1Y Price Target
$28.25Price Target Upside12.50% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering4
EPS Forecast (FY)1.59
Revenue Forecast (FY)$486.20M
MGP Ingredients Business Overview & Revenue Model
Company DescriptionMGP Ingredients, Inc., together with its subsidiaries, produces and supplies distilled spirits, branded spirits, and food ingredients. It operates through three segments: Distillery Products; Branded Spirits; and Ingredient Solutions. The Distillery Products segment provides food grade alcohol for beverage applications that include bourbon and rye whiskeys, as well as grain neutral spirits, including vodka and gin; and food-grade industrial alcohol, which is used as an ingredient in foods, personal care products, cleaning solutions, pharmaceuticals, and various other products. This segment also provides fuel-grade alcohol for blending with gasoline; distillers feed and related co-products, such as distillers feed and corn oil; and warehouse services, including barrel put away, storage, and retrieval services, as well as blending services. The Branded Spirits segment provides ultra-premium, premium, mid, and value branded distilled spirits. The Ingredient Solutions segment provides specialty wheat starches for food applications under the Fibersym, Resistant Starch, and FiberRite RW Resistant Starch names; specialty wheat proteins for food applications under the Arise and Proterra names; gluten-free textured pea proteins; commodity wheat starch for food and non-food applications; and commodity wheat proteins. The company sells its products directly or through distributors to manufacturers and processors of finished packaged goods or to bakeries primarily in the United States, the United Kingdom, Japan, Thailand, Mexico, and Canada. MGP Ingredients, Inc. was founded in 1941 and is headquartered in Atchison, Kansas.
How the Company Makes MoneyMGP Ingredients makes money primarily by manufacturing and selling (1) specialty food ingredients and (2) distilled alcohol products.
1) Specialty ingredients revenue: The company produces specialty wheat proteins, starches, fibers, and related grain-based ingredients that are sold B2B to food manufacturers and other industrial customers. Revenue is generated through contracted and spot sales of these ingredients, with pricing and volumes influenced by customer product demand, mix (higher-value specialty formulations vs. more commodity-like outputs), and input costs (notably grains and energy).
2) Distilled alcohol revenue: The company produces distilled spirits and other alcohol solutions at scale and sells them to customers in the beverage alcohol supply chain. This includes sales of new-make/bulk distilled spirits and other distilled alcohol products that customers may use for further processing, blending, or brand production. Revenue in this area is driven by gallons sold, product type/proof, and customer mix, and can be affected by industry supply-demand dynamics and inventory cycles.
3) Byproducts and co-products: As part of grain processing and distillation, the company generates co-products (e.g., feed-related byproducts). These are sold to third parties and contribute additional revenue, though typically smaller than the core specialty ingredients and distilled alcohol streams.
Key factors influencing earnings across the model include sales mix (specialty vs. more commoditized outputs), grain and other input costs, manufacturing utilization/efficiency, and demand conditions in packaged foods and beverage alcohol markets. Specific named partnerships or customer contract terms are not publicly detailed here; if required, null.
MGP Ingredients Earnings Call Summary
Earnings Call Date:Feb 25, 2026
(Q4-2025)
| % Change Since: |
Next Earnings Date:Apr 30, 2026
Earnings Call Sentiment Negative
The call presented a mixed picture: notable wins in branded Premium Plus performance (led by Penelope), improved cash generation and embedded productivity initiatives provide constructive foundations, and Ingredient Solutions shows signs of operational recovery. However, material near-term headwinds dominate: sharp declines in Distilling Solutions and overall sales and margins, a large non-cash goodwill impairment, persistent waste disposal costs, and a sizeable near-term cash outflow (Penelope earn-out) that pushes leverage higher. Management is taking strategic actions and expects recovery off lower 2026 baselines, but the magnitude of the declines and the expected challenging 2026 make the near-term outlook unfavorable.Q4-2025 Updates
Positive Updates
Penelope and Premium Plus Outperformance
Penelope Bourbon delivered exceptional growth (Nielsen-reported dollar sales +80% over the 52-week period), making it the second-fastest growing brand among the top 30 Premium Plus American whiskeys. Premium Plus portfolio outperformed the overall category by 900 basis points, with Premium Plus sales up 10% in Q4. Penelope also achieved a 100% increase in points of distribution and a 12% increase in velocity.
Strong Operating Cash Generation and Capital Discipline
Operating cash flows increased 19% to $122 million for FY2025. Barrel put-away was reduced from $33 million in 2024 to $19 million in 2025. Full-year CapEx was $32 million (down more than 50% YoY); 2026 CapEx is guided to ~$20 million. Excluding the Penelope earn-out, 2026 CFO is expected at $40–45 million and free cash flow $20–25 million.
Strategic Progress and Embedded Productivity
Management executed an enterprise strategic review, implemented senior leadership changes (new CMO, SVP Operations, SVP Strategy & Insights), and embedded productivity and cost-discipline into routines. Adjusted SG&A excluding reinstated incentives declined ~5% in Q4 and 4% for the full year, and A&P spending was realigned (A&P down 11% in Q4 and 23% for the year).
Ingredient Solutions Recovery and Growth Opportunity
Ingredient Solutions saw Q4 extrusion protein sales reach a new high and commercial demand remained strong. The key equipment outage was resolved in November. Management expects Ingredient Solutions 2026 sales of $140–150 million and gross margins in the mid-to-high teens, with strong double-digit sales growth anticipated as operational reliability improves.
Portfolio Rationalization and Marketing Refocus
Company initiated a cross-functional portfolio management process targeting rationalization of ~20% of the portfolio tail brands to reduce complexity and free resources. Branded Spirits A&P was ~12.5% of segment sales in 2025 and is expected to modestly increase to ~13.5% in 2026 with a planned >200% increase in digital media spend and streamlined agency approach to drive Premium Plus brands.
Distilling Solutions Strategic Repositioning
Despite a weak brown goods market, MGP has broadened premium white goods offerings, pursued private-label aged whiskey opportunities, and expanded warehouse services to deepen customer partnerships. Distilling customer alignment efforts led brown goods results to come modestly ahead of initial outlook.
FY2025 Core Adjusted Results
For full-year 2025 the company reported consolidated sales of $536 million, adjusted EBITDA of $116 million, and adjusted basic EPS of $2.85, demonstrating underlying adjusted profitability despite challenging trends.
Negative Updates
Significant Declines in Quarterly Results and Margins
Q4 consolidated sales decreased 23% year-over-year to $138 million. Consolidated gross profit fell 35% to $48 million and Q4 consolidated gross margin declined 630 basis points to 34.9%. Adjusted EBITDA for Q4 decreased 51% to $26 million and adjusted basic EPS decreased 60% to $0.63.
Distilling Solutions Sales and Profit Collapse
Distilling Solutions sales declined 47% in Q4 (including a 53% decline in brown goods). Full-year Distilling Solutions sales declined 45% and gross profit declined 52%. Management expects 2026 Distilling Solutions sales down ~35% and gross profit down ~40% versus 2025.
Large Non-Cash Goodwill and Intangible Impairment
Q4 net loss was $135 million, driven primarily by a discrete non-cash impairment charge of $153 million to reduce carrying amounts of goodwill and certain indefinite-lived intangible assets in the Branded Spirits segment. Reported basic EPS was a loss of $6.22 per share.
Elevated Leverage and Near-Term Cash Outflows
Management expects a $111 million Penelope earn-out payment in Q2 2026 and a planned refinancing of $201 million of convertible notes in Q4 2026. The Penelope payment will reduce 2026 operating cash flow by nearly $50 million and net debt leverage is expected to peak at approximately 3.75x in 2026.
Ingredient Solutions Waste Disposal and Operational Headwinds
Ingredient Solutions faced a key equipment outage (impacting Q3 and Q4) and elevated waste stream disposal costs that persisted through year-end. Management noted that a portion of disposal costs will persist in the near-to-medium term and that elimination of all waste costs is a multiquarter initiative.
Weakened 2026 Guidance Reflects Continued Pressure
2026 guidance assumes net sales of $480–500 million (down from $536M FY2025), adjusted EBITDA $90–98 million (down from $116M), and adjusted basic EPS $1.50–1.80 (down from $2.85). Q1 is expected to be the lowest quarter (~15% of full-year adjusted EBITDA).
Margin Pressure and Higher Relative SG&A
Full-year gross margin decreased 350 basis points to 37.2% in 2025. Adjusted SG&A increased 18% in Q4 as performance incentives were reinstated; total company SG&A is expected to be ~18% of sales in 2026 (up vs prior year primarily due to lower sales).
Industry Oversupply and Production Contraction
Industry indicators show continued weakness: TTP data through Oct 2025 reported domestic whiskey production down 26% TTM (down 29% six-month, 27% three-month). Management expects the broader spirits industry to remain below historical growth levels and 2026 likely another down year.
Company Guidance
Management guided 2026 net sales of $480–$500 million, adjusted EBITDA of $90–$98 million, and adjusted basic EPS of $1.50–$1.80 on roughly 21.4 million average shares, with a full‑year tax rate of ~27% (Q1 tax rate ~75% due to share‑based award vesting) and full‑year CapEx of ~$20 million; they expect Q1 adjusted EBITDA to be ~15% of the full‑year target (the lowest quarter). Segment and other assumptions: Branded Spirits down mid‑single digits with A&P ~13.5% of segment sales and modest gross‑margin improvement; Distilling Solutions sales down ~35% and gross profit down ~40% vs. 2025; Ingredient Solutions sales of $140–$150 million with gross margin in the mid‑to‑high teens (low‑teens in H1 improving in H2). They plan $13–$18 million net whiskey put‑away, expect a $111 million Penelope earn‑out in Q2 and a $201 million convertible note refinance in Q4 (net debt leverage to peak ~3.75x), project full‑year interest expense of ~$12 million, and disclose that the Penelope payment will reduce 2026 operating cash flow by nearly $50 million (excluding that payment, OCF $40–$45 million and free cash flow $20–$25 million).MGP Ingredients Financial Statement Overview
Summary
Fundamentals are mixed. Revenue is in a clear downcycle and FY2025 swung to a large net loss, but the balance sheet shows reduced debt and cash flow held up with higher operating cash flow and improved free cash flow.Income Statement
Revenue has moved into a downcycle, falling from $836.5M (2023) to $703.6M (2024) and then to $536.4M (2025), with the latest year down ~7.3%. Profitability deteriorated sharply: the company went from solid positive operating profit and net income in 2021–2024 (net margin ~4.9% in 2024) to a sizable net loss in 2025 (net income -$107.8M) and negative operating results. Strengths are the historically strong margins in 2021–2023 and the ability to remain profitable through 2024, but the 2025 collapse materially weakens earnings quality and near-term visibility.34
Negative
Balance Sheet
Leverage appears manageable for the business: total debt declined meaningfully to $213.1M in 2025 from $339.6M in 2024, and prior debt-to-equity levels were moderate (about 0.33–0.41 in 2022–2024). Equity remains sizable ($718.4M in 2025) versus the asset base ($1.24B), providing balance-sheet support. The key weakness is that profitability and returns weakened into 2024 and then turned negative in 2025, which can pressure equity over time if losses persist despite the reduced debt load.62
Positive
Cash Flow
Cash generation is a relative bright spot: operating cash flow increased to $121.5M in 2025 from $102.3M in 2024, and free cash flow rose to $76.0M from $31.1M (up ~22.2% per the provided growth figure). This indicates the company continued to generate cash despite the 2025 accounting loss, which helps liquidity and debt capacity. The main concern is variability—free cash flow dipped in 2023 versus 2022—and, given the 2025 earnings loss, investors will want confirmation that cash flow strength is sustainable rather than timing-driven.71
Positive
| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 536.38M | 703.63M | 836.52M | 782.36M | 626.72M |
| Gross Profit | 199.41M | 286.32M | 304.71M | 253.31M | 198.97M |
| EBITDA | -69.22M | 98.87M | 170.51M | 167.08M | 144.22M |
| Net Income | -107.81M | 34.66M | 107.47M | 109.46M | 91.31M |
Balance Sheet | |||||
| Total Assets | 1.24B | 1.41B | 1.39B | 1.16B | 1.04B |
| Cash, Cash Equivalents and Short-Term Investments | 18.46M | 25.27M | 18.39M | 47.89M | 21.57M |
| Total Debt | 266.61M | 339.64M | 301.86M | 245.76M | 243.26M |
| Total Liabilities | 519.07M | 573.24M | 543.28M | 412.57M | 397.20M |
| Stockholders Equity | 718.44M | 834.17M | 850.49M | 746.72M | 644.75M |
Cash Flow | |||||
| Free Cash Flow | 76.04M | 31.10M | 28.52M | 43.61M | 40.87M |
| Operating Cash Flow | 121.53M | 102.28M | 83.78M | 88.94M | 88.26M |
| Investing Cash Flow | -45.52M | -71.56M | -159.24M | -47.81M | -182.62M |
| Financing Cash Flow | -83.52M | -23.80M | 45.92M | -14.76M | 94.29M |
MGP Ingredients Technical Analysis
Negative
25.11
Price Trends
22.91
Negative
23.55
Negative
25.74
Negative
Market Momentum
-1.85
Positive
17.23
Positive
2.13
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For MGPI, the sentiment is Negative. The current price of 25.11 is above the 20-day moving average (MA) of 19.78, above the 50-day MA of 22.91, and below the 200-day MA of 25.74, indicating a bearish trend. The MACD of -1.85 indicates Positive momentum. The RSI at 17.23 is Positive, neither overbought nor oversold. The STOCH value of 2.13 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for MGPI.
MGP Ingredients Risk Analysis
MGP Ingredients disclosed 35 risk factors in its most recent earnings report. MGP Ingredients reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks
MGP Ingredients Peers Comparison
UnderperformOutperform
Sector (62)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
70 Outperform | $2.42B | 19.30 | 12.16% | ― | -1.13% | 24.34% | |
67 Neutral | $26.34B | 11.96 | 15.12% | 2.92% | -5.57% | 119.49% | |
65 Neutral | $10.74B | 12.09 | 19.93% | 3.41% | -4.59% | -19.19% | |
63 Neutral | $10.74B | 12.09 | 19.93% | 3.42% | -4.59% | -19.19% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
60 Neutral | $41.82B | 6.03 | 19.40% | 4.80% | 0.22% | -38.76% | |
46 Neutral | $364.03M | -4.82 | -13.30% | 2.00% | -21.53% | -113.89% |
* Consumer Defensive Sector Average
MGPI
MGP Ingredients
17.04
-12.64
-42.59%
SAM
Boston Beer
231.79
4.28
1.88%
BF.A
Brown Forman A
23.59
-9.57
-28.86%
STZ
Constellation Brands
151.91
-22.44
-12.87%
DEO
Diageo
74.60
-30.69
-29.15%
BF.B
Brown-Forman B
23.31
-10.48
-31.02%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.